SOBI:STO
Biovitrum
498,20Â SEK
arrow_upward
+0,93%(+4,60) 1Â D
6. nov., 17:29:36 GMT+1 · SEK
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for SOBI …
Ã…pne
483,00Â SEK
Høy
498,20Â SEK
Lav
479,00Â SEK
Markedsverdi
178,17Â mrd.
Snittvolum
341,57k
Volum
563,09k
P/E-forhold
26,46
52 u høy
498,20Â SEK
52Â u lav
314,40Â SEK
EPS
18,83Â SEK
Utestående aksjer
357,64Â mill.
Antall ansatte
2k
Ã…pne
483,00Â SEK
Høy
498,20Â SEK
Lav
479,00Â SEK
Markedsverdi
178,17Â mrd.
Snittvolum
341,57k
Volum
563,09k
P/E-forhold
26,46
52 u høy
498,20Â SEK
52Â u lav
314,40Â SEK
EPS
18,83Â SEK
Utestående aksjer
357,64Â mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Invezz
·
for 14 timer siden
Nasdaq stiger 1 % etter chip-gjenoppretting; Dow faller til tross for sterke jobbtall
Dagens Næringsliv
·
for 1 døgn siden
KI-aksjer faller videre – ny smell for Musk
ABC10
·
for 29 minutter siden
Tech stock sell-off raises questions about AI boom and data center growth | Dollars & Sense
Yahoo Finance
·
for 1 time siden
5 Best 52-Week Low NASDAQ Stocks to Buy According to Billionaires
Profil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Om Biovitrum
Administrerende direktørGuido Oelkers
Ansatte2,21k
Grunnlagt1939
Hovedkontor-
SektorHealth Care
Bransje-
Nettstedsobi.com